Takeda Pharmaceutical Co. Ltd. - Enterprise Value To Ebitda Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 9.37 as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Enterprise Value To Ebitda Ratio" stands at 9.37. This represents an increase of 3.42 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.42 percent compared to the value the year prior.
The 1 year change in percent is 13.42.
The 3 year change in percent is 7.97.

The Serie's long term average value is 8.87. It's latest available value, on 09/30/2025, is 5.63 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +22.59%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -6.08%.